Accelerating rapid diagnostic development with Optimer reagents

Watch as Dr David Bunka, Aptamer Group CTO, and Dr Edgar Goluch, QSM Diagnostics CEO, discuss the application of Optimer binders to the development of novel rapid diagnostics.

See how our partners at QSM Diagnostics have optimised the use of Optimer binders in their diagnostic assay to fundamentally change how infections are diagnosed.